Chinese Clinical Oncology

Articles Available on Medscape

• Non-Colorectal Non-Neuroendocrine Liver Metastasis
  Learn more about the surgical options for these types of liver metastases and outcomes in these patients.

  December 15, 2022

• The Role of Systemic Therapy in Melanoma Brain Metastases
  The therapeutic options available for melanoma brain metastases are limited, with poor outcomes. Could systemic therapies expand the treatment possibilities?

  November 15, 2022

• Treatment for Postoperative Recurrence of Pancreatic Cancer
  What are the treatment options for pancreatic cancer patients who develop disease recurrence after undergoing surgical resection?

  October 14, 2022

• Management of Complications From Brain Metastasis Treatment
  Treatment options for brain metastases can come with a range of potential side effects. How are these complications best managed?

  September 15, 2022

• Optimal Management of Brainstem Metastases
  The treatment and management of brainstem metastases can present unique clinical challenges. What current approaches should be considered?

  August 15, 2022

• Immunotherapy in Pancreatic Cancer -- An Emerging Role
  Immunotherapy may offer another promising treatment option for pancreatic cancer patients. This review looks at the outcomes of recent clinical trials.

  July 15, 2022

• Minimally Invasive Surgery for Pancreatic Cancer
  Does the latest available evidence support the use of minimally invasive surgery in pancreatic cancer patients?

  June 16, 2022

• Why Diagnosing Inflammatory Breast Cancer Is Hard and How to Overcome the Challenges
  Inflammatory breast cancer is an uncommon disease and can present a diagnostic challenge. Which factors may lead to missed or delayed diagnoses?

  May 16, 2022

• What Is the Best Systemic Treatment for Newly Diagnosed Inflammatory Breast Cancer?
  This article provides an overview of recently published research on systemic treatment options for newly diagnosed inflammatory breast cancer.

  April 15, 2022

• Integrating PARP Inhibitors Into the Management of Breast Cancer
  PARP inhibitors have shown promise as an effective targeted therapy for breast cancer. What is the current state of the evidence?

  March 15, 2022

• Neoadjuvant Therapy in Resectable Pancreatic Cancer
  Should neoadjuvant treatments be considered for patients with resectable pancreatic cancer? This article reviews the most recent literature.

  February 15, 2022

• Radiotherapy Intensification for Glioblastoma
  Does the intensification of radiotherapy lead to improved outcomes in glioblastoma?

  January 14, 2022

• Anti-Angiogenic Therapies in the Management of Glioblastoma
  Learn more about the agents targeting angiogenesis and the evolving role of these therapies in the treatment of glioblastoma.

  December 15, 2021

• High Risk of Recurrence for Grade II Meningioma
  Grade II meningioma is associated with a high risk of recurrence. Which factors may influence the recurrence rate?

  November 15, 2021

• Epidemiology of Gallbladder Cancer in the Unites States
  An examination of the national epidemiologic trends in gallbladder cancer provides insight into the incidence and risk factors for this malignancy.

  October 15, 2021

• Narrative Review of Sentinel Lymph Node Biopsy in Breast Cancer
  What has recent research shown about the use of sentinel lymph node biopsy in breast cancer? This review provides an update.

  September 15, 2021

• Sentinel Lymph Node in Cervical Cancer: Time To Move Forward
  Sentinel lymph node biopsy is shown to be a safe and effective alternative to pelvic lymph node dissection in cervical cancer. Is it time to consider it the gold-standard?

  August 16, 2021

• Hepatocellular Carcinoma, Novel Therapies on the Horizon
  Recent advancements have led to the identification and development of potential new treatment options for hepatocellular carcinoma.

  July 15, 2021

• Neoadjuvant and Adjuvant Treatment Approaches for Hepatocellular Carcinoma
  Learn more about the current neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma and the promising new options on the horizon.

  June 15, 2021

• Real-World Assessment of the Effect of Impact of Tumor Size on Pathological Complete Response Rates in Triple Negative Breast Cancer After Neoadjuvant Chemotherapy
  What impact might tumor size have on pathological complete response rates in triple negative breast cancer patients receiving neoadjuvant chemotherapy?

  May 17, 2021